Literature DB >> 18025240

Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.

Andreas A Hombach1, David Kofler, Anja Hombach, Gunter Rappl, Hinrich Abken.   

Abstract

The strength of immune repression by regulatory T (Treg) cells is thought to depend on the efficiency of Treg cell activation. The stimuli and their individual strength required to activate resting human Treg cells, however, have so far not been elucidated in detail. We reveal here that induction of proliferation of human CD4(+)C25(+) Treg cells requires an extraordinary strong CD28 costimulatory signal in addition to TCR/CD3 engagement. CD28 costimulation, noteworthy, cannot be substituted by IL-2 to induce proliferation of Treg cells, which is in contrast to CD4(+)CD25(-) T cells. IL-2, in contrast, prevents spontaneous apoptosis of Treg cells, but does not initiate their amplification. IL-2 and CD28 costimulation clearly exhibit disparate effects on Treg cells which are in contrast to those on CD4(+)CD25(-) T cells. Moreover, the prerequisites for Treg cell proliferation differ strikingly from those for effector T cells, implying a balanced orchestration in initiating and limiting a T cell immune response. In addition, data are of relevance for the design of therapeutic strategies involving IL-2 administration and CD28 costimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025240     DOI: 10.4049/jimmunol.179.11.7924

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.

Authors:  Anil Dangi; Tina L Sumpter; Shoko Kimura; Donna B Stolz; Noriko Murase; Giorgio Raimondi; Yoram Vodovotz; Chao Huang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

3.  Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.

Authors:  Kazuaki Chikamatsu; Koichi Sakakura; Minoru Toyoda; Katsumasa Takahashi; Takanori Yamamoto; Keisuke Masuyama
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

Review 4.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression.

Authors:  Yong Chen; Shudan Shen; Balachandra K Gorentla; Jimin Gao; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2012-01-09       Impact factor: 5.422

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

8.  Adoptive regulatory T-cell therapy protects against cerebral ischemia.

Authors:  Peiying Li; Yu Gan; Bao-Liang Sun; Feng Zhang; Binfeng Lu; Yanqin Gao; Weimin Liang; Angus W Thomson; Jun Chen; Xiaoming Hu
Journal:  Ann Neurol       Date:  2013-05-14       Impact factor: 10.422

9.  Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.

Authors:  Peiying Li; Leilei Mao; Xiangrong Liu; Yu Gan; Jing Zheng; Angus W Thomson; Yanqin Gao; Jun Chen; Xiaoming Hu
Journal:  Stroke       Date:  2014-02-04       Impact factor: 7.914

10.  Modulation of T-cell activation by malignant melanoma initiating cells.

Authors:  Tobias Schatton; Ute Schütte; Natasha Y Frank; Qian Zhan; André Hoerning; Susanne C Robles; Jun Zhou; F Stephen Hodi; Giulio C Spagnoli; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.